SCHEMBL4906833

SCHEMBL4906833

CCN(c1ccc(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.47
HDAC11 Q96DB2 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
UQCRB P14927 1/20 0.46
HIF1A Q16665 1/20 0.45
HCRTR2 O43614 1/20 0.45
PTPN5 P54829 1/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895884 0.92 HDAC8 (0.48) HDAC3HDAC11HDAC8HDAC6MAPT
SCHEMBL4904216 0.90 PTPN5 (0.53) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL4900672 0.89 HDAC8 (0.51) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL4905415 0.89 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL4904061 0.82 SERPINE1 (0.50) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL5378704 0.82 POLB (0.56) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL4902733 0.81 ESR1 (0.60) ALDH1A1MAPTNPSR1SMN1; SMN2LMNA
SCHEMBL4894519 0.81 HDAC8 (0.52) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL4905920 0.80 HDAC8 (0.54) HDAC3HDAC11HDAC8HDAC6ALDH1A1
SCHEMBL4897517 0.80 ALDH1A1 (0.49) ALDH1A1MAPTPOLBNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD HDAC3 176/4885HDAC11 718/4885HDAC8 959/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC3 157/4885HDAC11 657/4885HDAC8 882/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC3 157/4885HDAC11 657/4885HDAC8 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.